Results 71 to 80 of about 263 (128)

Investigating the psychometric properties of the Persian version of the Quality of Life Questionnaire for Women Infected with HPV (EQUALI-HPV). [PDF]

BMC Public Health
Arashlouei AZ, Maghsoudi SH, Irani M, Honarvar Z, Ahmadi A, Pereira-Caldeira NMV.   +5 more
europepmc   +1 more source

Human Papillomavirus in the region of La Ribera-Valencia: Present and future. [PDF]

Rev Esp Quimioter, 2020
Burgos-Teruel A, Bernet L, Gil-Tomás JJ, Jover-García J, López A, Osca A.   +5 more
europepmc   +1 more source

Comparison of Hybribio-H13 and Hybrid Capture® 2 human papillomavirus tests for detection of CIN2+ and CIN3. [PDF]

Biomedica
Agudelo MC, Torres-González E, Agudelo S, Ramírez AT, Castañeda KM, Kinslow CJ, Rodríguez-Herrera M, Garland L, Xie Y, Orozco CA, Stoler M, Dean M, Sánchez GI.   +12 more
europepmc   +1 more source

Effectiveness of high-risk human papillomavirus genotyping for cervical cancer screening. A multicentre screening cohort study in rural China. [PDF]

An Sist Sanit Navar
Yu YQ, Jiang MY, Zhang X, Pan QJ, Dang L, Feng RM, Ali NM, Chen W, Qiao YL.   +8 more
europepmc   +1 more source

Human papillomavirus genotyping using next generation sequencing (NGS) in cervical lesions: Genotypes by histologic grade and their relative proportion in multiple infections. [PDF]

PLoS One, 2022
Basiletti JA, Valls J, Poklépovich T, Fellner MD, Rol M, Alonso R, Correa RM, Colucci MC, Rodríguez de la Peña M, Falabella PG, Saíno A, Campos J, Herrero R, Almonte M, Picconi MA.   +14 more
europepmc   +1 more source

Eficacia de la Vacunación del Virus del Papiloma Humano (VPH) en mujeres de 22-47 años de Latinoamérica, Norteamérica y Europa, febrero a junio 2025

El objetivo de esta investigación fue analizar la eficacia de la vacunación del Virus del Papiloma Humano (VPH) en mujeres de 22-47 años de Latinoamérica, Norteamérica y Europa, de febrero a junio 2025.
Cunza Chicas, Dora Elizabeth, Turcios López, Flor Argentina   +1 more
core  

Imiquimod-Loaded Nanosystem for Treatment Human Papillomavirus-Induced Lesions. [PDF]

Pharmaceutics
Maocha I, Rosado B, Lopes-Nunes J, Lopes M, Rolo J, Pires B, Gallardo E, Palmeira-de-Oliveira A, Martinez-de-Oliveira J, Palmeira de Oliveira R, Medeiros R, Cruz C.   +11 more
europepmc   +1 more source

Efficacy and safety of cryotherapy, cold cone or thermocoagulation compared to LEEP as a therapy for cervical intraepithelial neoplasia: Systematic review. [PDF]

Rev Saude Publica, 2020
Hurtado-Roca Y, Hurtado-Roca Y, Becerra-Chauca N, Malca M.   +3 more
europepmc   +1 more source

Impact of knowledge of human papillomavirus positivity on cervical cytology performance in Latin America. [PDF]

J Natl Cancer Inst
Ramírez AT, Mesher D, Baena A, Salgado Y, Kasamatsu E, Cristaldo C, Álvarez R, Rojas FD, Ramírez K, Guyot J, Henríquez O, González Palma H, Flores B, Peñaranda J, Vero MJ, Robinson I, Rol ML, Rodríguez G, Terán C, Ferrera A, Picconi MA, Calderon A, Mendoza L, Wiesner C, Almonte M, Herrero R, ESTAMPA Study Group .   +26 more
europepmc   +1 more source

Odkrivanje raka materničnega vratu s testiranjem za visokorizične humane viruse papiloma

, 2009
Since the development of cytology-based cervical cancer screening using PAP test in the mid-20th century, the PAP test has been accepted as a method for secondary prevention of cervical cancer.
Marjetka Uršič-Vrščaj, Uršič-Vrščaj, Marjetka   +1 more
core